Company intelligence / Profile preview

Prepaire

Dublin, Ireland

Ownership: Private
Development stage: Other

Overview

Prepaire is building AI- and data-driven platforms (digital twins, autonomous labs, disease modeling app store) to support drug discovery, precision medicine, and regenerative medicine; it does not present itself as a therapeutic developer with its own clinical-stage drug candidates but rather as an enabling technology company.[1][3][4][5]

Industry: Drug Discovery Services

Partnerships

MGI Tech (ultra-high-throughput sequencing collaboration for drug discovery and precision medicine in the Middle East)[1]TruDiagnostic (exclusive UAE partnership for epigenetic testing integrated with GenetiQ digital twin platform)[5]

Beyond the preview

Go deeper on Prepaire.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prepaire.

Explore the full profile